MED-EL is a leading manufacturer of innovative medical devices for the treatment of various types and degrees of hearing loss. Our unique portfolio of implantable hearing solutions benefits thousands of individuals in more than 140 countries worldwide. With headquarters in Innsbruck, Austria, MED-EL has over 3,300 employees around the world.

CEO_12607
Business Developer - Therapeutics (m/f/d)
CEO Team
Innsbruck, Austria
Professionals Full-Time 38.5h Permanent

• Identification and expansion of new business opportunities in the therapeutics sector
• Establishment and maintenance of strategic partnerships with manufacturers, distributors, and other relevant market partners
• Analysis of the market, competition, target groups, and regulatory developments
• Development and implementation of new sales and marketing strategies
• Support for product launches, go-to-market activities, and market expansion
• Monitoring of relevant trends in Healthcare and Consumer Health
• Acquisition of new customers and development of long-term business relationships
• Derivation of strategic recommendations for the further development of the business area

• Completed degree in pharmacy, life sciences, healthcare management, or a comparable qualification, as well as experience in business development, sales, key account management, or product management, ideally in the pharmaceutical/healthcare sector
• Knowledge of regulatory requirements in the pharmaceutical sector is an advantage
• Very good German skills and business-fluent English skills
• Proficient in MS Office, CRM systems, and digital tools
• Entrepreneurial mindset, initiative, results orientation, team spirit, and strong communication and negotiation skills; analytical thinking and a good sense of market trends, business opportunities, and customer needs

• Central Location
• Employee Discounts
• Flexible Hours
• International Environment
• Onboarding
• Workplace Well-Being

Minimum Salary
Salary will be determined based on professional experience; the formal minimum salary according to Collective Bargaining Agreement is € 47,810.14.